United States · FDA National Drug Code directory
FULVESTRANT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16729-436_3001d1ed-b200-7d1b-e063-6394a90ab45f
- Product NDC
- 16729-436
- Form
- INJECTION
- Composition / generic term
- Fulvestrant
- Labeler
- Accord Healthcare Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210121
- Source listing expiry
- 20261231
Source-listed ingredients
- FULVESTRANT — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE, GLASS in 1 CARTON (16729-436-30) / 5 mL in 1 SYRINGE, GLASS (16729-436-31) · 16729-436-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →